A Randomized, Double-blind 2-arm, Followed by an Open-label 1-arm, NEPTUNUS Extension Study to Assess the Long-term Safety and Efficacy of Ianalumab in Patients With Sjogrens Syndrome.
Public ClinicalTrials.gov record NCT05985915. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-blind 2-arm, Followed by an Open-label 1-arm, NEPTUNUS Extension Study to Assess the Long-term Safety and Efficacy of Ianalumab in Patients With Sjögren's Syndrome
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to measure the long-term safety and tolerability of ianalumab in participants with Sjögren's syndrome who have previously completed treatment from one of two NEPTUNUS 1 year core studies (CVAY736A2301 \[NCT05350072\] or CVAY736A2302 \[NCT05349214\]).
Study identification
- NCT ID
- NCT05985915
- Recruitment status
- Active, not recruiting
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 612 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 27, 2023 (Actual)
- Primary completion
- Apr 22, 2033 (Estimated)
- Completion
- Apr 22, 2033 (Estimated)
- Last update posted
- Oct 15, 2026
2023 – 2033
United States locations
- U.S. sites
- 32
- U.S. states
- 17
- U.S. cities
- 30
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Providence Medical Foundation | Fullerton | California | 92835 | — |
| Advanced Medical Research | La Palma | California | 90623 | — |
| Medvin Clinical Research | Van Nuys | California | 91405 | — |
| Bay Area Arthritis And Osteoporosis | Brandon | Florida | 33511 | — |
| GNP Research | Cooper City | Florida | 33024 | — |
| Sarasota Arthritis Res Ctr | Sarasota | Florida | 34239 | — |
| West Broward Rheumatology Associates Inc | Tamarac | Florida | 33321 | — |
| Augusta University Georgia | Augusta | Georgia | 30912 | — |
| North GA Rheumatology Group PC | Suwanee | Georgia | 30024 | — |
| Clin Invest Specialists Inc | Orland Park | Illinois | 60467 | — |
| University of Kansas Hospital | Kansas City | Kansas | 66160 | — |
| Ochsner Health System | Baton Rouge | Louisiana | 70809 | — |
| The John Hopkins Jerome L Greene Sjogren | Baltimore | Maryland | 21224 | — |
| Tufts School of Dental Medicine | Boston | Massachusetts | 02111 | — |
| Arthritis Osteoporosis Assoc of NM | Las Cruces | New Mexico | 88011 | — |
| NYU Langone Hospital - Long Island | Mineola | New York | 11501 | — |
| St Lawrence Health System | Potsdam | New York | 13676 | — |
| Arthritis and Osteoporosis | Charlotte | North Carolina | 28202 | — |
| On Site Clinical Solutions Llc | Charlotte | North Carolina | 28202 | — |
| Carolina Arthritis Associates | Wilmington | North Carolina | 28401 | — |
| STAT Research Inc | Dayton | Ohio | 45402 | — |
| RAO Research LLC | Oklahoma City | Oklahoma | 73116 | — |
| Altoona Center for Clin Res | Duncansville | Pennsylvania | 16635 | — |
| West Tennessee Research Institute | Jackson | Tennessee | 38305 | — |
| Shelby Research LLC | Memphis | Tennessee | 38119 | — |
| Precision Comprehensive Research | Colleyville | Texas | 76034 | — |
| Baylor College Of Medicine | Houston | Texas | 77030 | — |
| Prolato Clinical Research Center | Houston | Texas | 77054 | — |
| Houston Rheumatology and Arthrit | Katy | Texas | 77494 | — |
| First Outpatient Research Unit | San Antonio | Texas | 78229 | — |
| Advanced Rheumatology of Houston | The Woodlands | Texas | 77382 | — |
| Arthritis Northwest PLLC | Spokane | Washington | 99216 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 166 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05985915, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 15, 2026 · Synced Oct 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT05985915 live on ClinicalTrials.gov.